CVRx, Inc. (CVRX)
NASDAQ: CVRX · Real-Time Price · USD
8.11
-0.34 (-4.02%)
At close: Jan 9, 2026, 4:00 PM EST
8.27
+0.16 (1.97%)
After-hours: Jan 9, 2026, 6:30 PM EST
CVRx, Inc. Market Cap
CVRx, Inc. has a market cap or net worth of $212.56 million as of January 9, 2026. Its market cap has decreased by -29.92% in one year.
Market Cap
212.56M
Enterprise Value
177.96M
1-Year Change
-29.92%
Ranking
Category
Stock Price
$8.11
Market Cap Chart
Since the IPO on June 30, 2021, CVRx, Inc.'s market cap has decreased from $347.31M to $212.56M, a decrease of -38.80%. That is a compound annual growth rate of -10.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 212.56M | 14.23% |
| Dec 31, 2025 | 186.09M | -39.47% |
| Dec 31, 2024 | 307.42M | -53.03% |
| Dec 29, 2023 | 654.44M | 73.26% |
| Dec 30, 2022 | 377.72M | 51.75% |
| Dec 31, 2021 | 248.90M | -28.33% |
| Jun 30, 2021 | 347.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |